The Clinical Coding and Schedule Development (CCSD) group develop and maintains procedural and diagnostics nomenclature for private payers in England.
The CCSD Group has approved the following diagnostic codes for publication to the CCSD Schedule in May 2019 with a recommended adoption date being the 1st
of August 2019:
- Hereditary Angioedema (HAE) SERPING 1 gene (0635G)
- Primary Hyperoxaluria Panel (3547G)
- Myeloid Panel (3018G)
See full details here